Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Peptide containing doai
Reexamination Certificate
2005-10-11
2009-11-10
Gupta, Anish (Department: 1654)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Peptide containing doai
C514S012200, C530S326000
Reexamination Certificate
active
07615534
ABSTRACT:
Artificially synthesized antimicrobial peptide that does not occur naturally is provided by the present invention. The antimicrobial peptide includes one unit, two units or more units of amino acid sequence composed of the following 8 amino acid residues:(R or Q)-(L or F or I)—I—K-(L or F or I or V)-L-Y-Q;and/or,modified sequence composed of said sequence with partial modification.
REFERENCES:
patent: 5547939 (1996-08-01), Selsted
patent: 5789542 (1998-08-01), McLaughlin et al.
patent: 5807746 (1998-09-01), Lin et al.
patent: 5877282 (1999-03-01), Nadler et al.
patent: 5962415 (1999-10-01), Nadler
patent: 6043339 (2000-03-01), Lin et al.
patent: 6180604 (2001-01-01), Fraser et al.
patent: 6191254 (2001-02-01), Falla et al.
patent: 6303575 (2001-10-01), Selsted
patent: 6476189 (2002-11-01), Yamakawa et al.
patent: 2005/0171335 (2005-08-01), Kourai et al.
patent: 2007/0248584 (2007-10-01), Kent
patent: 2001186887 (2001-07-01), None
patent: WO9926971 (1991-06-01), None
patent: 9402610 (1994-02-01), None
patent: 9636692 (1996-11-01), None
patent: 9851794 (1998-11-01), None
patent: 9926971 (1999-06-01), None
patent: 9929721 (1999-06-01), None
patent: 9967284 (1999-12-01), None
patent: 0009553 (2000-02-01), None
patent: 0059527 (2000-10-01), None
patent: 0109175 (2001-02-01), None
patent: 0210201 (2002-02-01), None
patent: 03091429 (2003-11-01), None
patent: WO2004056391 (2004-07-01), None
Beven et al, Effects on mollicutes (wall-less bacteria) of synthetic peptides comprising a signal peptide or a membrane fusion peptide, and a nuclear localization sequence (NLS) a comparison with melittin, Biochim Biophys Acta Oct. 23, 1997; 1329(2), pp. 357-369.
Chaloin et al, Ionic Channels formed by a primary amphipathic peptide containing a signal peptide and a nuclear localization sequence, Biochim Biophys Acta Oct. 15, 1998; 1375(1-2), pp. 52-60.
Shai, From innate immunity to de-novo designed antimicrobial peptides, Current Pharmaceutical Design, 2002, vol. 8, No. 9, Apr. 1, 2002, pp. 715-725.
Goode et al, Identification of a novel microtubule binding and assembly domain in the developmentally regulated inter-repeat region of tau, The Journal of Cell Biology, vol. 124 (1994), pp. 769-782.
Goode et al, Functional interactions between the proline-rich and repeat regions of tau enhance microtubule binding and assembly, Molecular Biology of the Cell, vol. 8 (1997), pp. 353-365.
Bergen et al, Assembly of protein into Alzheimer paired helical filaments depends on a local sequence motif forming structure, PNAS, vol. 97, No. 10 (2000), pp. 5129-5134.
Kubota et al, A cis-acting peptide signal in a human immunodeficiency virus type I Rev which inhibits nuclear entry of small proteins, Oncogene, vol. 16 (1998), pp. 1851-1861.
Fang et al, Trans-Dominant Negative HIV Type 1 Rev with Intact Domains of NLS/NOS and NES, AIDS Research and Human Retroviruses, vol. 18, No. 10 (2002), pp. 705-708.
Kobayashi Nahoko
Kourai Hiroki
Yamada Yoshinao
Yoshida Tetsuhiko
Gupta Anish
Toagosei Co., Ltd
Turocy & Watson LLP
LandOfFree
Antimicrobial peptides and use thereof does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Antimicrobial peptides and use thereof, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Antimicrobial peptides and use thereof will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4113329